Profile
Jan-Erik Nyström is the founder of TIRmed Pharma AB, which was founded in 2018, where he holds the title of Chairman.
He currently holds the position of Director at Stiftelsen Gunnar Och Elsa Jaderlunds Minne.
Mr. Nyström's former positions include Chief Executive Officer at Alveiro AB and Independent Director at Sprint Bioscience AB. He received an undergraduate degree from the Royal Institute of Technology.
Jan-Erik Nyström active positions
| Companies | Position | Start |
|---|---|---|
TIRmed Pharma AB
TIRmed Pharma AB Pharmaceuticals: MajorHealth Technology Develops topical eczema treatment solutions | Founder | 2017-12-31 |
Stiftelsen Gunnar Och Elsa Jaderlunds Minne | Director/Board Member | - |
Former positions of Jan-Erik Nyström
| Companies | Position | End |
|---|---|---|
Alveiro AB | Chief Executive Officer | - |
| SPRINT BIOSCIENCE AB | Director/Board Member | - |
Training of Jan-Erik Nyström
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Royal Institute of Technology
Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sprint Bioscience AB
Sprint Bioscience AB Pharmaceuticals: MajorHealth Technology Develops medicines in the field of cancer and metabolism | Health Technology |
Alveiro AB | |
TIRmed Pharma AB
TIRmed Pharma AB Pharmaceuticals: MajorHealth Technology Develops topical eczema treatment solutions | Health Technology |
Stiftelsen Gunnar Och Elsa Jaderlunds Minne |
- Stock Market
- Insiders
- Jan-Erik Nyström
















